5E9D image
Deposition Date 2015-10-15
Release Date 2016-06-08
Last Version Date 2024-11-06
Entry Detail
PDB ID:
5E9D
Keywords:
Title:
RD-1 Mart-1 High bound to Mart-1 decameric peptide (ELA) in complex with HLA-A2
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.51 Å
R-Value Free:
0.23
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HLA class I histocompatibility antigen, A-2 alpha chain
Chain IDs:A, F
Chain Length:275
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Beta-2-microglobulin
Gene (Uniprot):B2M
Chain IDs:B, G
Chain Length:100
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Melanoma derived Mart-1 peptide
Mutations:A2L
Chain IDs:C, H
Chain Length:10
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:A6-TCR Valpha
Gene (Uniprot):TRAV12-2
Chain IDs:D, I
Chain Length:129
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:A6-TCR Vbeta
Gene (Uniprot):TRBV6-5
Chain IDs:E, J
Chain Length:156
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
An Engineered Switch in T Cell Receptor Specificity Leads to an Unusual but Functional Binding Geometry.
Structure 24 1142 1154 (2016)
PMID: 27238970 DOI: 10.1016/j.str.2016.04.011

Abstact

Utilizing a diverse binding site, T cell receptors (TCRs) specifically recognize a composite ligand comprised of a foreign peptide and a major histocompatibility complex protein (MHC). To help understand the determinants of TCR specificity, we studied a parental and engineered receptor whose peptide specificity had been switched via molecular evolution. Altered specificity was associated with a significant change in TCR-binding geometry, but this did not impact the ability of the TCR to signal in an antigen-specific manner. The determinants of binding and specificity were distributed among contact and non-contact residues in germline and hypervariable loops, and included disruption of key TCR-MHC interactions that bias αβ TCRs toward particular binding modes. Sequence-fitness landscapes identified additional mutations that further enhanced specificity. Our results demonstrate that TCR specificity arises from the distributed action of numerous sites throughout the interface, with significant implications for engineering therapeutic TCRs with novel and functional recognition properties.

Legend

Protein

Chemical

Disease

Primary Citation of related structures